Learn with Anil · APPSC Group-I PYQsPractise online →Subscribe ₹149
LVM3 lifting off with Chandrayaan-3 from Sriharikota, Andhra Pradesh

Photo: LVM3 launch, Sriharikota, ISRO, GODL-India

APPSC Group-I Mains 2025 · Paper V

2025 Paper V · Q15(b): model answer

Science, Technology & Environmental Issues · Science and technology policy, institutions and IPR. Held in May 2025 (Notification 12/2023).

Q15(b)10 marks2025 · Paper V

Describe the importance of IPR in academic and industrial research collaborations.

Syllabus: Science and technology policy, institutions and IPR · Intellectual property rights

Model answer · free

Intellectual property rightsAcademia–industry collaborationTechnology transferLicensing and royalties

Intellectual property rights (IPR), such as patents, copyrights, designs, trade secrets and plant-variety rights, give creators exclusive rights for a limited time. In academia–industry collaborations, universities bring knowledge and talent while firms bring money, scale and markets. Clear IP terms decide who owns the results, who may use them and how gains are shared; without them, inventions stay in laboratories and partnerships end in disputes. India's National IPR Policy, 2016 makes commercialisation of research a priority.

1. Why IPR matters in collaborations

  • Clarity and trust: agreements define background IP (what each partner brings) and foreground IP (what is created), so partners can invest without fear of losing control.
  • Incentive for industry: firms fund research only if they can secure exclusive or preferred rights; a patent also attracts investors to start-ups and spin-offs.
  • Revenue for universities and public labs: licence fees and royalties fund further research; ICMR, for instance, received royalties on sales of Covaxin, which it co-developed with Bharat Biotech.
  • Credit for researchers: inventors are named on patents and share income, rewarding applied work.
  • Openness with protection: a short review period before publication lets patents be filed without blocking academic freedom.
Joint research under a signed agreement
Invention disclosed to the transfer office
Patent filed in agreed names
Licence or spin-off company
Product reaches market; royalties shared
From laboratory to market

2. Key clauses of a collaboration agreement

ClauseWhat it settles
Background IPPre-existing know-how each partner brings and how it may be used
Foreground IPOwnership of new results: sole, joint or by contribution
LicensingExclusive or non-exclusive; field and territory
Revenue sharingRoyalties, milestone payments, inventors' share
Publication and confidentialityReview period before papers; non-disclosure agreements
Disputes and exitArbitration, jurisdiction, termination terms
What a good collaboration agreement settles

3. Indian initiatives

  • Policy: the National IPR Policy, 2016 ("Creative India; Innovative India") with CIPAM under DPIIT; the National IP Awareness Mission (2021) for colleges; an 80% patent-fee cut for educational institutions (2021 rules).
  • Funding and institutions: IPR cells and technology transfer offices in IITs and CSIR laboratories; BIRAC and Atal Innovation Mission incubators; ANRF (2023) and the ₹1 lakh crore RDI scheme (2025) to draw private money into research.
  • Success story: NexCAR19 (2023), India's first CAR-T cell therapy, was developed by IIT Bombay and Tata Memorial and commercialised through the IIT Bombay-incubated ImmunoACT.

4. Challenges

  • Weak commercialisation: few university patents are licensed; many institutions lack clear IP policies and trained IP managers.
  • Low R&D base: national R&D spending is 0.84% of GDP (2023-24), and industry funds little university research.
  • Legal gaps: no law like the US Bayh–Dole Act (1980) on publicly funded IP; the 2008 Bill on it was never passed; patent backlogs persist.

AP angle: newer institutions such as IIT Tirupati and IISER Tirupati, the AP MedTech Zone in Visakhapatnam and ANGRAU need model agreements and technology transfer offices to link research with local industry.

IPR is the bridge between laboratory and market; model agreements, professional transfer offices and fair benefit-sharing can turn India's rising innovation (Global Innovation Index rank 38th, 2026) into products and jobs.

The other choice in Q15

Answer either one in the exam.

  1. Q15(a)Discuss the transmission dynamics of respiratory tract infections in densely populated urban settings. Propose effective public health strategies for their prevention.

    10 marks · Biotechnology and health · Health and diseases

Write better answers: the Answer Writing Tool Kit

Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.

₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking

Get it for ₹149